Clinical efficacy and safety of perampanel monotherapy as primary anti‐seizure medication in the treatment of pediatric epilepsy: A single‐center, prospective, observational study
Abstract Objective To assess the efficacy and safety of perampanel (PER) as primary monotherapy in patients aged 4–18 years old with epilepsy. Methods A single‐center, prospective, observational study was conducted from October 2021 to October 2023, to evaluate PER monotherapy's efficacy and safety...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2024-12-01
|
| シリーズ: | Epilepsia Open |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/epi4.13043 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|